Skip to main content

Table 1 Patient characteristics

From: Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction – a prospective cohort pilot study within a randomized clinical trial

Characteristics Chemotherapy (n = 23) Chemoradiotherapy (n = 17) P
Age years median (range) 62 (46–71) 66 (56–75) 0.09
Male/Female 19/4 15/2 1.00
BMI median (range) 23 (18–33) 26 (21–35) 0.06
Weight change kg median (range) −10 (−24, +2) −10 (−21, +6) 0.62
Tumor type    
Adenocarcinoma, n (%) 16 (70) 13 (76) 0.73
Squamous-cell carcinoma, n (%) 7 (30) 4 (24) 0.73
Clinical T stage    
T1 0 0 _
T2 9 4 _
T3 14 13 _
Clinical N stage    
N0 5 3 >0.99
N1 18 14 >0.99
Cardiovascular disease, n (%) 7 (30) 10 (59) 0.11
Hypertension, n (%) 7 (30) 9 (53) 0.20
Ischemic heart disease, n (%) 1 (4) 2 (12) 0.56
Smoking ongoing or previous, n (%) 10 (43) 4 (24) 0.32
COPD, n (%) 5 (22) 1 (6) 0.22
Anemia, n (%) 6 (26) 4 (23) 1.00
Diabetes, n (%) 3 (13) 3 (18) 1.00
ASA class, n I/II/III/IV 0/15/8/0 0/10/7/0 0.75
  1. BMI, Body mass index; COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiologists.